Meloxicam Kleva 15 Mg (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which is a key step in the production of prostaglandins that cause inflammation, pain, and fever. By reducing prostaglandin synthesis at inflamed sites, meloxicam diminishes swelling and pain while sparing COX‑1 activity.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Dosage may vary, and patients should follow the specific instructions provided by their prescriber.

Safety of meloxicam in pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the potential risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Meloxicam is more COX‑2 selective than many traditional NSAIDs, which can result in a lower incidence of gastrointestinal irritation while still providing effective analgesic and anti‑inflammatory action. However, it still carries cardiovascular and renal risks similar to other NSAIDs, so patient factors must be considered.

Meloxicam tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Meloxicam is taken orally as a tablet, usually with a full glass of water. It may be taken with or without food, but taking it with food can help reduce possible stomach upset.

Serious risks include gastrointestinal ulceration or bleeding, severe liver injury, cardiovascular events such as heart attack or stroke, and life‑threatening allergic reactions (anaphylaxis). Patients should seek immediate medical attention if they experience symptoms like severe abdominal pain, jaundice, chest pain, or swelling of the face and throat.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, and in patients with significant renal or hepatic impairment unless specifically directed by a physician.